Pinnacle Medicines

Transforming patients' lives with oral peptides

DOYLESTOWN, United States · Founded 2024 · $89.0M raised

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$89.0M
Last Round
$89.0M Series BMar 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Pinnacle Medicines is a biotechnology company focused on developing a new generation of oral peptide therapeutics designed to deliver biologic-level efficacy in pill form for patients with chronic diseases. The company is pioneering macrocyclic peptide chemistry to create first-in-class oral drugs targeting conditions including asthma, COPD, and metabolic disorders such as obesity. Founded in 2024 and headquartered in Doylestown, Pennsylvania, Pinnacle raised a $134 million total in funding including an oversubscribed $89 million Series B to advance its pipeline into clinical trials, backed by investors including OrbiMed.

Summary

Pinnacle Medicines is a Biotech company based in DOYLESTOWN, United States, founded in 2024. It has raised $89.0M in total across 1 round, most recently a $89.0M Series B round in Mar 2026. Investors include OrbiMed.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2026
$89.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pinnacle Medicines on Indexed.vc
<a href="https://indexed.vc/companies/pinnacle-medicines"><img src="https://indexed.vc/api/badge/company/pinnacle-medicines" alt="Pinnacle Medicines on Indexed.vc" width="260" height="76" /></a>